Development of Piperazine- and Oxazine-Linked Pyrimidines as p65 Subunit Binders of NF–κB in Human Breast Cancer Cells

Nuclear factor kappa B (NF–κB) is a potential therapeutic target in breast cancer. In the current study, a new class of oxazine– and piperazine–linked pyrimidines was developed as inhibitors of NF–κB, overcoming the complexity of the oxazine structure found in nature and enabling synthesis under lab...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravish, Akshay, Narasimhachar, Bhanuprakash C., Xi, Zhang, Vishwanath, Divakar, Mohan, Arunkumar, Gaonkar, Santosh L., Chandrashekara, Paduvalahippe Gowdegowda, Ahn, Kwang Seok, Pandey, Vijay, Lobie, Peter E., Basappa, Basappa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604619/
https://www.ncbi.nlm.nih.gov/pubmed/37893090
http://dx.doi.org/10.3390/biomedicines11102716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604619/
https://www.ncbi.nlm.nih.gov/pubmed/37893090
http://dx.doi.org/10.3390/biomedicines11102716

Ejemplares similares